Alectinib In the Treatment of Systemic Juvenile Xanthogranuloma of Infancy With ALK Translocation

JAMA Dermatol. 2023 Dec 1;159(12):1399-1401. doi: 10.1001/jamadermatol.2023.4027.

¹ Department of Dermatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
² Department of Pathology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
³ Department of Radiology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
⁴ Department of Hematology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

No abstract available

Plain language summary

This observational case series examines the diagnosis and treatment of 2 patients with systemic juvenile xanthogranuloma treated with alectinib.